4,239 reports of this reaction
2.0% of all FISH OIL reports
#9 most reported adverse reaction
DYSPNOEA is the #9 most commonly reported adverse reaction for FISH OIL, manufactured by Fresenius Kabi USA, LLC. There are 4,239 FDA adverse event reports linking FISH OIL to DYSPNOEA. This represents approximately 2.0% of all 214,316 adverse event reports for this drug.
Patients taking FISH OIL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for FISH OIL, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for FISH OIL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 4,239 FDA reports for FISH OIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.0% of all adverse event reports for FISH OIL, making it a notable side effect.
If you experience dyspnoea while taking FISH OIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.